Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05414994 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Assessment of the Ocular Microbiome in Health and Disease

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. 2 versions Re-verified since Sep 30, 2025, no change to tracked fieldsv7-v8
  2. Primary completion date: Sep 30, 2026 to Sep 30, 2027
    • Study completion date: Dec 30, 2026 to Dec 30, 2027
    • Interventions: Eye swab (Other)
    v6
  3. Enrollment target: 140 to 500v5 Show 7 more changesShow less
    • Primary completion date: Jun 30, 2024 to Sep 30, 2026
    • Start date: Jul 20, 2022 to Sep 7, 2023
    • Study completion date: Jun 30, 2024 to Dec 30, 2026
    • Secondary endpoints: details revised at 1 of 1 entry
    • Study arms: 7 to 6
    • Eligibility criteria shortened, about 4 words
    • Study title shortened, about 2 words
  4. 2 versions Re-verified since Aug 1, 2023, no change to tracked fieldsv3-v4
  5. Trial status: Not Yet Recruiting to Recruitingv2 Show 5 more changesShow less
    • Enrollment target: 60 to 140
    • Study sites: 0 to 1
    • Start date changed from estimate of Jun 30, 2022 to Jul 20, 2022
    • Eligibility criteria expanded, about 23 words
    • Study arms: 3 to 7
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of this application is to illustrate the core constituents of the ocular surface microbiome, describe factors that promote colonization, and assess the ocular microbiome's role in the health of the anterior segment. We will conduct a prospective, observational cohort study, including a longitudinal analysis of the ocular microbiome in adults.
Trial Details
NCT Number NCT05414994
Lead Sponsor Vanderbilt University Medical Center
Conditions
(from sponsor)		 Microbial Colonization, Eye Diseases, Ophthalmopathy
Related terms Communicable Diseases, Eye Diseases
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov